Skip to main content

AZN research · 13F holders by reporting quarter

Astrazeneca PLC (AZN): 13F holders, 2025Q3

The largest share positions in AZN that the managers Kresmion follows reported on Form 13F for 2025Q3, as filed. The current quarter, the company's SEC filings and its recent events are on the AZN research page.

AZN positions held by the managers we follow (2025Q3)

What the managers we follow bought and sold in Q3 2026

Manager / securityMarket value% of reported value
CITADEL ADVISORS LLC FundCUSIP 046353108 · 2025Q3$275.1M0.22%
MILLENNIUM MANAGEMENT LLC FundCUSIP 046353108 · 2025Q3$170.9M0.13%
Point72 Asset Management, L.P. FundCUSIP 046353108 · 2025Q3$43.7M0.09%
TWO SIGMA INVESTMENTS, LP FundCUSIP 046353108 · 2025Q3$39.7M0.06%
Bridgewater Associates, LP FundCUSIP 046353108 · 2025Q3$35.5M0.14%
D. E. Shaw & Co., Inc. FundCUSIP 046353108 · 2025Q3$17.8M0.01%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. A Form 13F-HR is due 45 days after the quarter ends, or on the next business day when that day falls on a weekend or a US federal holiday.